The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease

Lydia Roets, Declan Doherty, Rebecca Delaney, Anna Krasnodembskaya, Marcus A Mall, Cliff Taggart, Sinead Weldon

Research output: Contribution to conferencePosterpeer-review


Mesenchymal stem cells (MSCs) are spindle-shaped multipotent cells with immunomodulatory and reparative properties, which can be found in the mesenchymal stroma or connective tissues of the body. An ongoing pre-clinical study within our lab has found MSC-based therapy to significantly reduce inflammation and tissue damage in the lungs of Scnn1b-transgenic mice. These mice exhibit a chronic inflammatory lung disease due to airway-specific overexpression of the β-subunit of the epithelial sodium channel. Subsequently, we investigated whether administration of the MSC secretome, in a complementary cell-free approach, would exert similar effects. Scnn1b-transgenic mice were subcutaneously injected with control media or MSC-conditioned media (MSC-CM) every second day from birth to postnatal day 12, after which they were sacrificed at postnatal day 14. Analysis of the bronchoalveolar lavage fluid revealed significant reductions in both polymorphonuclear neutrophils and eosinophils in mice treated with MSC-CM. Histological analyses revealed that MSC-CM administration significantly improved two parameters of lung damage – the mean linear intercept and the destructive index. Overall, these results highlight the potential of the MSC secretome to limit lung damage and/or promote pulmonary repair/regeneration in the Scnn1b-transgenic mouse model of chronic lung disease.
Original languageEnglish
Publication statusPublished - 2019
EventEuropean Respiratory Society International Congress 2019 - Spain, Madrid, Spain
Duration: 28 Sept 201902 Oct 2019


ConferenceEuropean Respiratory Society International Congress 2019
Abbreviated titleERS 2019
Internet address


  • Mesenchymal stem cell (MSC)
  • MSC secretome
  • pulmonary repair/regeneration
  • chronic lung disease
  • Scnn1b-transgenic mouse model
  • beta ENaC mice


Dive into the research topics of 'The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease'. Together they form a unique fingerprint.

Cite this